Target (CBDY) Accounts Payables (2013 - 2026)
Target (CBDY) reported Accounts Payables of $2.9 million for Q1 2026, up 27.01% year-over-year from $2.3 million in Q1 2025, and up 10.94% quarter-over-quarter from $2.6 million in Q4 2025.
Target (CBDY) Accounts Payables (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of Accounts Payables data on file, last reported at $2.9 million in Q1 2026.
- Accounts Payables for Q1 2026 came in at $2.9 million, up 27.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 million (up 27.01% YoY), and the FY2025 annual result was $2.6 million, down 14.7% from the prior year.
- Accounts Payables rose to $2.9 million in Q1 2026 per CBDY's latest filing, from $2.6 million in the prior quarter.
- Over five years, Accounts Payables peaked at $4.3 million in Q3 2022 and troughed at $1.7 million in Q2 2022.
- A 5-year average of $2.7 million and a median of $2.7 million in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables soared 121.48% in 2022, then tumbled 38.0% in 2023.
- A 5-year view of Accounts Payables shows it stood at $2.3 million in 2022, then rose by 28.24% to $2.9 million in 2023, then increased by 4.99% to $3.1 million in 2024, then decreased by 14.7% to $2.6 million in 2025, then gained by 10.94% to $2.9 million in 2026.
- Business Quant data shows CBDY's Accounts Payables at $2.9 million in Q1 2026, $2.6 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | Target | - | - | 191,787.00 | 2.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.93 Mn |
| Dec 31, 2025 | 2.64 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Mar 31, 2025 | 2.30 Mn |
| Dec 31, 2024 | 3.09 Mn |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 2.95 Mn |
| Sep 30, 2023 | 2.67 Mn |
| Jun 30, 2023 | 2.82 Mn |
| Mar 31, 2023 | 2.61 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Sep 30, 2022 | 4.31 Mn |
| Jun 30, 2022 | 1.68 Mn |
| Mar 31, 2022 | 3.33 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 2.06 Mn |
| Jun 30, 2021 | 2.00 Mn |